Skip to main content
Clinical Trials/CTRI/2021/09/036845
CTRI/2021/09/036845
Not yet recruiting
未知

INTRAVASCULAR ULTRASOUND (IVUS) DERIVED PLAQUE CHARACTERISTICS AND OUTCOMES IN ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS INTERVENTIO

Society for Coronary Imaging and Physiology SCIP0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: I249- Acute ischemic heart disease, unspecified
Sponsor
Society for Coronary Imaging and Physiology SCIP
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Society for Coronary Imaging and Physiology SCIP

Eligibility Criteria

Inclusion Criteria

  • Patients who are undergoing IVUS guided PCI for diagnosis of
  • 1\)ST elevation myocardial infarction (STEMI): Defined as chest pain with \> 1mm STE in 2 contigous leads except V2 \& V3\. In V2 \& V3, STE of \> 2mm in males \& \> 1\.5mm in females
  • 2\)Non ST elevation myocardial infarction (NSTEMI): Defined as chest pain with ECG changes consistent with new ischemia ( ST depression , T inversions ) with troponin elevation
  • 3\. Unstable angina: Defined as chest pain at rest or minimal effort with or without ECG changes and no biomarker elevation

Exclusion Criteria

  • 1\)cardiogenic shock \- as defined by SBP \< 90mmHg (/ need for inotropic support to maintain perfusion ) \+ evidence of end organ hypoperfusion \- altered sensorium / oliguria
  • 2\)Hemodynamic instability \- as defined by recurrent VT / acute pulmonary oedema / need for ventilator support / mechanical cardiac support \- or any instance where operator feels performing imaging is not possible due to clinical instability
  • 3\)Stent thrombosis / restenosis \- any stent failure related vessel
  • 4\)Graft interventions
  • 5\)Inability to perform either pre or post IVUS images
  • 6\)Mechanical complications
  • 7\)Planned CABG in next 30 days
  • 8\)Severe comorbidities which restrict life span to \< 1 year
  • 9\)Presenting eGFR \< 30 ml/min/m2
  • 10\)Age \< 18 \& \>90 years

Outcomes

Primary Outcomes

Not specified

Similar Trials